Siepmann, J.
Inserm,
France
2024 Rank: 28702
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Polymers
Rank in SubField 1: 143 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28702 | 31520 |
| Total Cites | 1111 | 1199 |
| H-index | 14 | 14 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 610 | 621 |
| Number of Single+First+Last Authored Papers | 139 | 139 |
| Total Cites to Single+First+Last Authored Papers | 813 | 860 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 837 | 868 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.38 |
| Self-Citation Percentage |
7.34%
|
|
Siepmann, J.
Médicaments et Biomatériaux à Libération Contrôlée : Mécanismes et Optimisation (MBLC),
France
2023 Rank: 47889
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Polymers
Rank in SubField 1: 274 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 47889 | 50197 |
| Total Cites | 1027 | 1099 |
| H-index | 12 | 14 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 600 | 611 |
| Number of Single+First+Last Authored Papers | 135 | 135 |
| Total Cites to Single+First+Last Authored Papers | 765 | 798 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 816 | 845 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.30 |
| Self-Citation Percentage |
6.55%
|
|
Siepmann, J.
Université de Lille,
France
2022 Rank: 26874
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Polymers
Rank in SubField 1: 134 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26874 | 30750 |
| Total Cites | 1142 | 1221 |
| H-index | 14 | 14 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 662 | 674 |
| Number of Single+First+Last Authored Papers | 124 | 124 |
| Total Cites to Single+First+Last Authored Papers | 873 | 908 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 852 | 872 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.40 |
| Self-Citation Percentage |
6.47%
|
|
Siepmann, J.
Université de Lille,
France
2021 Rank: 21660
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Polymers
Rank in SubField 1: 110 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 21660 | 23945 |
| Total Cites | 1792 | 1898 |
| H-index | 18 | 19 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 1060 | 1085 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 1379 | 1435 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1351 | 1387 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.37 |
| Self-Citation Percentage |
5.58%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.